Results 161 to 170 of about 38,416 (212)
NTM-host matched infection models for the classification of drug efficacy against rapid and slow growing nontuberculous mycobacteria species. [PDF]
Sci RepGuglielmi VE +4 more
europepmc +1 more source
Prevalence and drug resistance profiles of nontuberculous mycobacteria isolated from Iranian fish pond waters. [PDF]
Sci RepCui X +8 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Seminars in Respiratory and Critical Care Medicine, 2021
AbstractNontuberculous mycobacteria (NTM) are ubiquitous in the environment and 193 species of NTM have been discovered thus far. NTM species vary in virulence from benign environmental organisms to difficult-to-treat human pathogens. Pulmonary infections remain the most common manifestation of NTM disease in humans and bronchiectasis continues to be a
Shera, Tan, Shannon, Kasperbauer
openaire +2 more sources
AbstractNontuberculous mycobacteria (NTM) are ubiquitous in the environment and 193 species of NTM have been discovered thus far. NTM species vary in virulence from benign environmental organisms to difficult-to-treat human pathogens. Pulmonary infections remain the most common manifestation of NTM disease in humans and bronchiectasis continues to be a
Shera, Tan, Shannon, Kasperbauer
openaire +2 more sources
Drug Susceptibility Testing of Nontuberculous Mycobacteria
Future Microbiology, 2014 Item does not contain fulltextDiseases caused by nontuberculous mycobacteria are emerging in many settings. With an increased number of patients needing treatment, the role of drug susceptibility testing is again in the spotlight.
Ed J Kuijper, Jakko van Ingen
exaly +2 more sources
2008
This chapter focuses on nontuberculous mycobacteria (NTM), organisms that are ubiquitous in the environment and are thus referred as “environmental mycobacteria” by some experts. Mycobacterium avium complex (MAC), which includes M. kansasii, M. fortuitum, and M. abscessus, is the most common NTM associated with human disease in the United States.
Timothy Aksamit, David E. Griffith
openaire +1 more source
This chapter focuses on nontuberculous mycobacteria (NTM), organisms that are ubiquitous in the environment and are thus referred as “environmental mycobacteria” by some experts. Mycobacterium avium complex (MAC), which includes M. kansasii, M. fortuitum, and M. abscessus, is the most common NTM associated with human disease in the United States.
Timothy Aksamit, David E. Griffith
openaire +1 more source
Outbreaks of nontuberculous mycobacteria
Current Opinion in Infectious Diseases, 2017Purpose of reviewThe purpose of this review is to summarize the emerging literature on nontuberculous mycobacteria outbreaks in healthcare settings. As our ability to identify mycobacterial species develops, we are better able to recognize epidemiologic connections and better understand the prevalence and importance of these outbreaks and pseudo ...
Geeta, Sood, Nikki, Parrish
openaire +2 more sources
Current Opinion in Pulmonary Medicine, 1997
The nontuberculous mycobacteria (NTM), especially Mycobacterium avium complex, are being recognized with increasing frequency as clinical pathogens, not only as a cause of disseminated disease in patients with AIDS but also as a cause of chronic lung disease in patients without AIDS. These infections have traditionally been difficult and frustrating to
openaire +2 more sources
The nontuberculous mycobacteria (NTM), especially Mycobacterium avium complex, are being recognized with increasing frequency as clinical pathogens, not only as a cause of disseminated disease in patients with AIDS but also as a cause of chronic lung disease in patients without AIDS. These infections have traditionally been difficult and frustrating to
openaire +2 more sources